← Back to patent-cliff list
TQD-3524
Tier C — Watch / tradeTQD-3524
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Hospital-acquired pneumonia, Gram-negative bacterial infection
Regional status
US
-
EU
-
China
Phase II
2026-07-21
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of TQD-3524?
Approved indications include: Hospital-acquired pneumonia, Gram-negative bacterial infection.
When does the TQD-3524 patent expire?
No public expiry year is available for TQD-3524 yet; this page updates once verified.
How do I get a quote for TQD-3524 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29